рак толстой кишкиадъювантная терапияхимиотерапия1.Барсуков Ю.А., Кныш В.И. Современные возможности лечения колоректального рака. Соврем. онкол. 2006; 8 (2): 7–16.2.Andre Т, Colin Р, Louvet С et al. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks adjuvant therapy in stage II and III colon cancer: results of а randomized trial. J Clin Oncol 2003; 21 (15): 2896–903.3.Andre Т, Boni С, Mounedji-Boudiaf et al. Oxaliplatin, fluorouracil and leucovorinas adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343–51.4.Arnold D, Schmoll H-J. (Neo-) adjuvant treatment in colorectal cancer. Ann Oncol 2005; 15 (Suppl. 2): 133–40.5.Cassidy J, Twelves С, Nowacki М et al. Improved safety of capecitabine versus bolus 5fluorouracil/leucovorin adjuvant therapy for colon cancer (the Х-АСТ phase III study). Gastrointestinal Cancer Symposium 2004; Abstr. 219.6.Cervantes А, Chirivella I, Rodrigllez-Braun Е et al. А multimodality approach to localized rectal cancer. Ann Oncol 2006; 17 (Suppl. 10): 129–34.7.De Gramont А, Boni С, Navarro М et al. Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results оп the MOSAIC tria1, including survival, with а median follow - up of six years. ASCO 2007;25 (suppl. 1): abstr. 4007.8.Feig В, Chang G. Sentinel node assessment in colorectal сапl potential advantages and obstacles. ASCO 2007 Ed. Book. 196–8.9.GiIl S, Loprizini C.L., Sargent D.J. et al. Pooled analysis of fluorouracil - based adjuvant therapy for stage II and III соlon cancer: Who benefits and bу haw much? J Clin Oncol 2004; 22(10): 1–10.10.Gray R.G., Barnwel1 J, Hills R et аl. QUASAR: А randomized study of adjuvant chemotherapy vs observation including 3238 colorectal canсеr patients. Рrос ASCO 2004; аbstr. 3501.11.Glynne-Jones R, Sebag-Montefiore D, Маngаhn TS et al. А phase I dose escalation study of continuous oral capecitabine with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. Ann Oncol 2006; 17: 50–6.12.Наllеr D.G., Catalano P.J., Macdonald J.S., Мауег R.J. Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: Five - year final report of INT-0089. Proc ASCO, 1998; аbstr. 982.13.Hamaguchi T, Shirao К, Moriya Y et al. Adjuvant chemotherapy with uracil - tegafur (UFT) for stage III colorectal cancer: Final results of randomized trials bу the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC). Proc ASCO 2007; 25: abstr. 4049.14.International Multicentre Pooled Ana1ysis of Colon Cancer Trials (IМPАСТ) investigators efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995; 345(8955): 939–44.15.International Multicentre Pooled analysis of В2 Colon Cancer Trials (IMPACT 82) Investigators Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J Clin Oncol 1999; 17: 1356–63.16.Johnston Р. Clinical or molecular factors for treatment decision. Ann Oncol 2006; 17 (Suppl. 9): 37.17.Kalоfоnоs Н.Р., Pentheroudakis G, Rigatos S et al. А rаndоmаsеd phasе III trial of adjuvant radiochemotherapy соmрaring irinоtесаn (СРТ-11), 5FU and leucovorin to 5FU and leucovorin in patients with rectal cancer. Ann Oncol 2006; 17 (Suppl. 9): Abstr. 3320 (Р. 116).18.Корес J.A., Yothers G, Ganz Р.А. et al. Сравнение качества жизни операбельных больных раком ободочной кишки на фоне перорального и внутривенного введения химиопрепаратов: результаты исследования С-06, проведенного в рамках National Surgical Аdjuvаnt Breast and Bowel Project. J Clin Оnсоl (рус. изд.) 2007; 25(4): 424–30.19.Moertel C.G., Flеming T.R., Масdоnаld J.C. et al. Fluorouracil plus levamisole as effective adjuvant therapy of resected colon саrсinоmа. N Engl J Med 1990; 332(6): 235–8.20.Moertel C.G., Fleming T.R., Macdonald J.C. et al. Fluorouracil plus levamisole as effective аdjuvаnt therapy after resection of stage III соlоп саrсinоmа: А finаl report. Ann Intеrn Med 1995; 122: 321–6.21.О'Соnеll M.J., Laurie J.A., Каhn М et аl. Prospectively rаndоmizеd trial of postoperative adjuvant chemotherapy in patients with high - risk соlon cancer. J Clin Oncol 1998; 16(1): 295–300.22.O'Dwyer P.J., Eckhardt S.G., Haller D.G. et аl. Recommendation of Gаstrоintеstinаl Scientific Leadership Council of the Coalition of Cancer Cooperative Groups. J Clin Оnсоl 2007; 25: 2313–21.23.QUASAR Collaborative group, Comparison of fluorouracil with аdditiоnаl levamisole, higher - dose folinic acid, or botl1, as аn adjuvant chemotherapy for colorectal саnсеr: а randomized trial. Lancet 2000; 355: 1588–96.24.Saini А, Norman A.R., Cunningham D et аl. Twelve weeks of protracted venus infusion of fluorouracil is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer. Br J Cancer 2003; 88: 1859–65.25.Sargent D.J., Goldberg R.M., Jacobson S.D. et al. А pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001; 345(15): 1091–7.26.Sargent D.J., Wieand S, Benedetti J et al. Disease - free survival vs overall survival as а primary endpoint for аdjuvаnt colon cancer studies: individual patients data fron 12, 915 patients оп 15 randomised trials. Proc ASCO 2004; abstr. 3502.27.Sauer R, Becker Н, Hohenberger W et al. Preoperative chemo/radiotherapy as compared with post - operative chemo/radiotherapy for locally advanced rectal cancer. N Engl J Med 2004; 351: 1731–40.28.Tepper J.E., O'Conell M.J., Petroni G.R. et al. Adjuvant postoperative fluоrоurасil - mоdulаtеd chemotherapy combined with pelvic radiation therapy for rectal cancer: Initial results of Intergroup 0114. J Clin Oncol 1997; 15: 2030–9.29.Twelves С, Scheithauer W, McKendrick J et al. 5-year overall survival update from Х-АСТ trial of capecitabine vs 5-FU/LV as adjuvant therapy for stage III colon cancer. Еur J Cancer 2007; 5 (5? suppl.): 384 (Ро6587).30.Van Cutsem Е, Labianka R, Hossteld D et al. Randomized phase III trial comparing infused irinotecan/5-fluоrоnrасil/folinic acid versus 5FU/FA in stage III colon cancer patients (РЕТАСС-3). Proc ASCO 2005; 24: abstr.31.Wiggers Т. Multidisciplinary treatment of loсаllу advanced rectal cancer. Eur J Cancer 2007; 5 (5, suppl.): 375–6.32.Wolmark N, Wickerham D.I., Fisher В et аl. Postoperative adjuvant therapy for Dukes В and С adenocarcinoma: In "NIН Consensus Development Conference Adjuvant Therapy for patients with colon and rectum cancer". 1990; 45–6.33.Wolmark N, Rockette Н, Mamounas Е et al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil and leucovorin and levamisole in patients with Dukes' В and С carcinoma of the colon: results from National Surgical Adjuvant Breast and bowel Project С-О4. J Clin Oncol 1999; 17(11): 3553–9.